11
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Long-Term Survival in Prostatic Carcinoma, with Special Reference to Age as a Prognostic Factor: A Nation-Wide, Study

, , &
Pages 107-112 | Accepted 10 Jun 1985, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

E. Jonsson, H. P. Sigbjarnarson, J. Tomasson, K. R. Benediktsdottir, L. Tryggvadottir, J. Hrafnkelsson, E. J. Olafsdottir, H. Tulinius & J. G. Jonasson. (2006) Adenocarcinoma of the prostate in Iceland: A population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987. Scandinavian Journal of Urology and Nephrology 40:4, pages 265-271.
Read now
P. Iversen & S. T. Torp-Pedersen. (1991) Screening for Prostatic Cancer: Investigational models. Acta Oncologica 30:2, pages 281-284.
Read now
Per Carlsson, Hans Hjertberg, Bengt Jönsson & Eberhard Varenhorst. (1989) The Cost of Prostatic Cancer in a Defined Population. Scandinavian Journal of Urology and Nephrology 23:2, pages 93-96.
Read now

Articles from other publishers (28)

Andreas Thorstenson, Hans Garmo, Jan Adolfsson & Ola Bratt. (2017) Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study. Journal of Urology 197:1, pages 61-66.
Crossref
Rob C. M. Pelger, Guus a. B. Lycklama À Nijeholt, Aeilko H. Zwinderman & Neveen A. T. Hamdy. (2002) Estramustine phosphate combined with orchidectomy as first‐line therapy in patients with prostate carcinoma. Cancer 94:10, pages 2596-2601.
Crossref
Gabriel Sandblom, Monika Dufmats & Eberhard Varenhorst. (2000) Long-term survival in a swedish population-based cohort of men with prostate cancer. Urology 56:3, pages 442-447.
Crossref
Can Öbek, Shenghan Lai, Samih Sadek, Francisco Civantos & Mark S Soloway. (1999) Age as a prognostic factor for disease recurrence after radical prostatectomy. Urology 54:3, pages 533-538.
Crossref
KLAUS BRASSO, SOREN FRIIS, KNUD JUEL, TORBEN JORGENSEN & PETER IVERSEN. (1999) MORTALITY OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER TREATED WITH OBSERVATION FOR 10 YEARS OR LONGER: A POPULATION BASED REGISTRY STUDY. Journal of Urology 161:2, pages 524-528.
Crossref
J. E. Altwein, M. Wirth, H. Rübben & T. Otto. 1998. Prostatakarzinom — Pathologie, Praxis und Klinik. Prostatakarzinom — Pathologie, Praxis und Klinik 63 165 .
J. E. Altwein. 1997. Uroonkologie. Uroonkologie 233 399 .
Jonas Hugosson, Gunnar Aus & Lars Norlén. (1996) SURVEILLANCE IS NOT A VIABLE AND APPROPRIATE TREATMENT OPTION IN THE MANAGEMENT OF LOCALIZED PROSTATE CANCER. Urologic Clinics of North America 23:4, pages 557-573.
Crossref
Yoshiyuki Kakehi, Hiroya Oka, Kenji Mitsumori, Noriyuki Itoh, Osamu Ogawa & Osamu Yoshida. (1996) Elevation of serum transforming growth factor-β1 Level in patients with metastatic prostate cancer. Urologic Oncology: Seminars and Original Investigations 2:5, pages 131-135.
Crossref
Gary M. Freedman, Alexandra L. Hanlon, W.Robert Lee & Gerald E. Hanks. (1996) Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. International Journal of Radiation Oncology*Biology*Physics 35:2, pages 243-250.
Crossref
B. J. Norlén. 1996. Carcinoma of the Prostate. Carcinoma of the Prostate 97 103 .
G. AusJ. HugossonL. Norlen. (1995) Need for Hospital Care and Palliative Treatment for Prostate Cancer Treated with Noncurative Intent. Journal of Urology 154:2, pages 466-469.
Crossref
J.-E. Johansson. 1995. Epidemiology of Prostate Disease. Epidemiology of Prostate Disease 225 238 .
S. T. Torp-Pedersen & P. Iversen. 1995. Screening des Prostatakarzinoms. Screening des Prostatakarzinoms 257 285 .
Henrik Grönberg, Jan-Erik Damber, Håkan Jonsson & Per Lenner. (1994) Patient Age as a Prognostic Factor in Prostate Cancer. Journal of Urology 152:3, pages 892-895.
Crossref
Jan Adolfsson, Gunnar Steineck & Willet F. Whitmore. (1993) Recent results of management of palpable clinically localized prostate cancer. Cancer 72:2, pages 310-322.
Crossref
P. Iversen & S. T. Torp-Pedersen. 1993. Malignancies of the Genitourinary Tract. Malignancies of the Genitourinary Tract 1 24 .
Jan-Erik Johansson, Theodor Sigurdsson, Lars Holmberg & Reinhold Bergstrom. (1992) Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer. An analysis of prognostic factors in 300 population-based consecutive cases. Cancer 70:6, pages 1556-1563.
Crossref
Jan-Erik Johansson, Swen-Olof Andersson, Lars Holmberg & Reinhold Bergström. (1991) Prognostic Factors in Progression-Free Survival and Corrected Survival in Patients with Advanced Prostatic Cancer: Results from a Randomized Study Comprising 150 Patients Treated with Orchiectomy or Estrogens. Journal of Urology 146:5, pages 1327-1332.
Crossref
Seth P. Lerner, Carie Seale-Hawkins, C. Eugene Carlton & Peter T. Scardino. (1991) The Risk of Dying of Prostate Cancer in Patients with Clinically Localized Disease. Journal of Urology 146:4, pages 1040-1045.
Crossref
Willet F. Whitmore, John A. Warner & Ian M. Thompson. (1991) Expectant management of localized prostatic cancer. Cancer 67:4, pages 1091-1096.
Crossref
Kyoichi Imai, Takanori Suzuki, Mikio Kobayashi, Hidetoshi Yamanaka, Yukio Tomaru & Jin Sato. (1990) The Significance of Erythrocyte Sedimentation Rate as a Prognostic Factor for Patients with Prostate Cancer: Gunma Urological Oncology Study Group Investigation. Japanese Journal of Cancer Research 81:10, pages 971-974.
Crossref
O. A. Haugen & O. Mjølnerød. (1990) DNA-ploidy as prognostic factor in prostatic carcinoma. International Journal of Cancer 45:2, pages 224-228.
Crossref
T. A. McNicholas. 1990. Lasers in Urology. Lasers in Urology 63 82 .
Deborah Borek, David Butcher, Khatab Hassanein & Frederick Holmes. (2006) Relationship of age to histologic grade in prostate cancer. The Prostate 16:4, pages 305-311.
Crossref
Peter T. Scardino. (1989) Early Detection of Prostate Cancer. Urologic Clinics of North America 16:4, pages 635-655.
Crossref
Jan-Erik Johansson, Swen-Olof Andersson, Ulla Brith Krusemo, Hans-Olov Adami, Reinhold Bergström & Wolfgang Kraaz. (1989) NATURAL HISTORY OF LOCALISED PROSTATIC CANCER. The Lancet 333:8642, pages 799-803.
Crossref
R. Friedrichs, H. Rübben, W. Lagrange & W. Lutzeyer. 1987. 38. Tagung, 23.–28. September 1986, Würzburg. 38. Tagung, 23.–28. September 1986, Würzburg 136 137 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.